• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散加权成像能否作为一种可靠的序列用于检测肺恶性结节和肿块?

Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?

机构信息

Department of Radiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, No. 1630, Dongfang Road, Pudong, Shanghai 200127, China.

出版信息

Magn Reson Imaging. 2013 Feb;31(2):235-46. doi: 10.1016/j.mri.2012.07.009. Epub 2012 Aug 16.

DOI:10.1016/j.mri.2012.07.009
PMID:22902469
Abstract

Recent developments in diffusion-weighted magnetic resonance imaging (DWI) make it possible to image malignant tumors to provide tissue contrast based on difference with the diffusion of water molecules among tissues, which can be measured by the apparent diffusion coefficient (ADC) value. We aimed to assess the diagnostic accuracy of DWI for benign/malignant discrimination of pulmonary nodules/masses with a meta-analysis. The MEDLINE, EMBASE, Cancerlit and Cochrane Library database, from January 2001 to August 2011, were searched for studies evaluating the diagnostic accuracy of DWI for benign/malignant discrimination of pulmonary nodules. We determined sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LRP and LRN), and constructed summary receiver operating characteristic SROC) curves. Across 10 studies (545 patients), there was no evidence of publication bias (P=.22, bias=-19.19). DWI had a pooled sensitivity of 0.84 (95% CI, 0.76-0.90) and a pooled specificity of 0.84 (95% CI, 0.64-0.94). Overall, LRP was 5.3 (95% CI, 2.1-13.0) and LRN was 0.19 (95% CI, 0.12-0.30). In patients with high pretest probabilities, DWI enabled confirmation of malignant pulmonary lesion; in patients with low pretest probabilities, DWI enabled exclusion of malignant pulmonary lesion. Worst-case-scenario (pretest probability, 50%) posttest probabilities were 84% and 16% for positive and negative DWI results, respectively. Diffusion-weighted magnetic resonance imaging can be used to differentiate malignant from benign pulmonary lesions. High-quality prospective studies regarding DWI in the evaluation of pulmonary nodules are still needed to be conducted.

摘要

磁共振弥散加权成像(DWI)的最新进展使得对恶性肿瘤进行成像成为可能,根据水分子在组织间扩散的差异提供组织对比,这可以通过表观弥散系数(ADC)值来测量。我们旨在通过荟萃分析评估 DWI 对肺结节/肿块良恶性鉴别诊断的准确性。我们检索了 MEDLINE、EMBASE、Cancerlit 和 Cochrane Library 数据库,检索时间为 2001 年 1 月至 2011 年 8 月,以评估 DWI 对肺结节良恶性鉴别诊断的准确性的研究。我们确定了研究之间的敏感性和特异性,计算了阳性和阴性似然比(LRP 和 LRN),并构建了汇总受试者工作特征(SROC)曲线。在 10 项研究(545 例患者)中,没有证据表明存在发表偏倚(P=.22,偏倚=-19.19)。DWI 的汇总敏感性为 0.84(95%CI,0.76-0.90),汇总特异性为 0.84(95%CI,0.64-0.94)。总的来说,LRP 为 5.3(95%CI,2.1-13.0),LRN 为 0.19(95%CI,0.12-0.30)。在术前概率较高的患者中,DWI 能够确认恶性肺病变;在术前概率较低的患者中,DWI 能够排除恶性肺病变。最差情况(术前概率,50%)的 DWI 阳性和阴性结果的术后概率分别为 84%和 16%。弥散加权磁共振成像可用于鉴别恶性和良性肺病变。仍需要开展关于 DWI 在肺结节评估中的高质量前瞻性研究。

相似文献

1
Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?弥散加权成像能否作为一种可靠的序列用于检测肺恶性结节和肿块?
Magn Reson Imaging. 2013 Feb;31(2):235-46. doi: 10.1016/j.mri.2012.07.009. Epub 2012 Aug 16.
2
A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.扩散加权 MRI 检测恶性肺结节和肿块的准确性的系统评价和荟萃分析。
Acad Radiol. 2014 Jan;21(1):21-9. doi: 10.1016/j.acra.2013.09.019.
3
Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography.磁共振扩散加权成像在诊断恶性肺结节/肿块中的应用:与正电子发射断层扫描的比较
J Thorac Oncol. 2008 Apr;3(4):358-64. doi: 10.1097/JTO.0b013e318168d9ed.
4
On the utility of quantitative diffusion-weighted MR imaging as a tool in differentiation between malignant and benign thyroid nodules.定量扩散加权磁共振成像作为鉴别甲状腺良恶性结节工具的效用
Acad Radiol. 2014 Mar;21(3):355-63. doi: 10.1016/j.acra.2013.10.008. Epub 2013 Dec 12.
5
Value of diffusion-weighted imaging for the discrimination of pancreatic lesions: a meta-analysis.扩散加权成像对胰腺病变鉴别价值的 Meta 分析。
Eur J Gastroenterol Hepatol. 2012 Feb;24(2):134-42. doi: 10.1097/MEG.0b013e32834eff37.
6
Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography.恶性与良性肺结节及肿块的扩散加权成像诊断效能:与正电子发射断层扫描的比较
Asian Pac J Cancer Prev. 2014;15(11):4629-35. doi: 10.7314/apjcp.2014.15.11.4629.
7
Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?扩散加权磁共振成像能否鉴别肺良恶性结节?
AJR Am J Roentgenol. 2008 Aug;191(2):464-70. doi: 10.2214/AJR.07.3133.
8
Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis.全身扩散加权磁共振成像对原发性和转移性恶性肿瘤检测的诊断价值:一项荟萃分析。
Eur J Radiol. 2014 Feb;83(2):338-44. doi: 10.1016/j.ejrad.2013.11.017. Epub 2013 Dec 4.
9
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.扩散加权磁共振成像在肝硬化肝脏中肝细胞癌和发育异常结节特征描述中的作用
J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.
10
Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules.表观扩散系数值及弥散加权磁共振成像在甲状腺良恶性结节鉴别诊断中的作用。
Clin Imaging. 2012 Jan-Feb;36(1):1-7. doi: 10.1016/j.clinimag.2011.04.001.

引用本文的文献

1
Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET/MR in patients with non-small cell lung cancer.18F-FDG PET/MR 代谢参数和表观扩散系数对非小细胞肺癌患者的预测价值。
BMC Med Imaging. 2024 Oct 29;24(1):290. doi: 10.1186/s12880-024-01445-8.
2
Effectiveness of Apparent Diffusion Coefficient Values in Predicting Pathologic Subtypes and Grade in Non-Small-Cell Lung Cancer.表观扩散系数值在预测非小细胞肺癌病理亚型和分级中的有效性
Diagnostics (Basel). 2024 Aug 16;14(16):1795. doi: 10.3390/diagnostics14161795.
3
State of the Art: Lung Cancer Staging Using Updated Imaging Modalities.
最新技术:使用更新的成像方式进行肺癌分期
Bioengineering (Basel). 2022 Sep 22;9(10):493. doi: 10.3390/bioengineering9100493.
4
Correlation between apparent diffusion coefficient and Ki-67 in different pathological types of lung cancer.不同病理类型肺癌的表观扩散系数与Ki-67之间的相关性
Transl Cancer Res. 2021 Dec;10(12):5364-5371. doi: 10.21037/tcr-21-2515.
5
Pulmonary Nodule and Mass: Superiority of MRI of Diffusion-Weighted Imaging and T2-Weighted Imaging to FDG-PET/CT.肺结节与肿块:扩散加权成像和T2加权成像的MRI相对于FDG-PET/CT的优势
Cancers (Basel). 2021 Oct 14;13(20):5166. doi: 10.3390/cancers13205166.
6
Novel Insights of T2-Weighted Imaging: Significance for Discriminating Lung Cancer from Benign Pulmonary Nodules and Masses.T2加权成像的新见解:对鉴别肺癌与良性肺结节及肿块的意义
Cancers (Basel). 2021 Jul 23;13(15):3713. doi: 10.3390/cancers13153713.
7
How to Discriminate Lung Cancer From Benign Pulmonary Nodules and Masses? Usefulness of Diffusion-Weighted Magnetic Resonance Imaging With Apparent Diffusion Coefficient and Inside/Wall Apparent Diffusion Coefficient Ratio.如何鉴别肺癌与良性肺结节及肿块?基于表观扩散系数和内部/壁表观扩散系数比值的扩散加权磁共振成像的效用
Clin Med Insights Oncol. 2021 Jul 7;15:11795549211014863. doi: 10.1177/11795549211014863. eCollection 2021.
8
Whole-Lesion Apparent Diffusion Coefficient Histogram Analysis: Significance for Discriminating Lung Cancer from Pulmonary Abscess and Mycobacterial Infection.全病灶表观扩散系数直方图分析:对鉴别肺癌与肺脓肿及分枝杆菌感染的意义
Cancers (Basel). 2021 May 31;13(11):2720. doi: 10.3390/cancers13112720.
9
Combination Assessment of Diffusion-Weighted Imaging and T2-Weighted Imaging Is Acceptable for the Differential Diagnosis of Lung Cancer from Benign Pulmonary Nodules and Masses.扩散加权成像和T2加权成像联合评估可用于肺癌与良性肺结节及肿块的鉴别诊断。
Cancers (Basel). 2021 Mar 28;13(7):1551. doi: 10.3390/cancers13071551.
10
Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.弥散加权全身成像(DWIBS)联合背景抑制技术对肺癌转移或复发的检测具有有效性和经济性。
Thorac Cancer. 2021 Mar;12(5):676-684. doi: 10.1111/1759-7714.13820. Epub 2021 Jan 21.